Thomas N. Krausz to Ipilimumab
This is a "connection" page, showing publications Thomas N. Krausz has written about Ipilimumab.
Connection Strength
0.196
-
Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma. J Clin Oncol. 2021 08 20; 39(24):2647-2655.
Score: 0.196
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.